Overview of Metabolomics in Research of Hypertension
10.13422/j.cnki.syfjx.20200240
- VernacularTitle:代谢组学在高血压研究中的应用
- Author:
Shuai CHEN
1
;
Shan-shan WEI
1
;
Yong JIA
1
;
Wen-hui CHEN
1
;
Deng-cheng LU
1
Author Information
1. Yunnan University of Chinese Medicine, Kunming 650500, China
- Publication Type:Research Article
- Keywords:
metabolomics;
hypertension;
pathogenesis;
syndromes;
pharmacological mechanism
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2020;26(2):210-217
- CountryChina
- Language:Chinese
-
Abstract:
Hypertension is one of the most common chronic diseases, also an important risk factor for a series of cardio-and cerebra-vascular diseases. Due to its polygenic, multi-factorial nature and heterogeneity, the underlying cause has not been fully elucidated, satisfied therapeutic effect hasn't been totally achieved either. Metabolomics is used to evaluate metabolic changes of organisms from a holistic perspective, associating with biological processes to reveal the whole situation of the body. In recent years, researchers have used metabolomics to study the pathogenesis of hypertension, potential biomarkers, effects of lifestyle interventions, and mechanisms of antihypertensive drugs. Targeted or untargeted ways are applied to study metabolites form blood, urine, or tissues of human or animals. Metabolic pathways of gut microflora, oxidative stress, fatty acids, and amino acids have drawn more attention, and the discovered metabolites may become potential biomarkers, further the diagnostic biomarkers and treatment targets. In addition, traditional Chinese medicine (TCM) is an integrated complex system in syndrome diagnosis and treatment, and metabolomics coincides well with the concepts of it. TCM researchers also use this method to study the biological basis of syndromes in hypertension and the mechanism of antihypertensive Chinese medicine. There are significant differences in the metabolites between different syndromes. TCM treatments can restore the metabolite disturbance caused by high pressure, which is probably one of the pharmacological pathways of antihypertensive Chinese medicine. Metabolomic studies in hypertension have achieved great progress, but there're still challenges in data analysis, integration with other metabolomic studies and other omic studies and causal relationship in further study.
